Granahan Investment Management, LLC Cytosorbents Corp Transaction History
Granahan Investment Management, LLC
- $2.78 Billion
- Q1 2024
A detailed history of Granahan Investment Management, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Granahan Investment Management, LLC holds 3,044,833 shares of CTSO stock, worth $2.62 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,044,833
Previous 3,618,143
15.85%
Holding current value
$2.62 Million
Previous $4.02 Million
27.99%
% of portfolio
0.1%
Previous 0.13%
Shares
23 transactions
Others Institutions Holding CTSO
# of Institutions
53Shares Held
17.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC3.17MShares$2.73 Million0.27% of portfolio
-
Skylands Capital, LLC2.88MShares$2.47 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.68 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.91MShares$1.64 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.37MShares$1.18 Million0.29% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $37.5M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...